Q: Please describe this drug.
 The Compound can be represented with the SMILES CCCCCc1cccc(CC(=O)O)c1.
Answer: Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome).
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCCCc1cccc(CC(=O)O)c1
CCCCCC1=CC(=CC=C1)CC(=O)O
2-(3-pentylphenyl)acetic acid
Please describe this drug.